SEC Comment Letter 0000000000-24-008517 to T2 Biosystems, Inc. (TTOO) (CIK 0001492674)
T2 Biosystems, Inc. (TTOO) (CIK 0001492674)
Date: July 26, 2024 · CIK: 0001492674 · Accession: 0000000000-24-008517
AI Filing Summary & Sentiment
File numbers found in text: 333-280922
Letter
July 26, 2024 John Sperzel Chief Executive Officer T2 Biosystems, Inc. 101 Hartwell Ave. Lexington, MA 02421 Re:T2 Biosystems, Inc. Registration Statement on Form S-3 Filed July 19, 2024 File No. 333-280922 Dear John Sperzel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Evan G. Smith
Show Raw Text
July 26, 2024
John Sperzel
Chief Executive Officer
T2 Biosystems, Inc.
101 Hartwell Ave.
Lexington, MA 02421
Re:T2 Biosystems, Inc.
Registration Statement on Form S-3
Filed July 19, 2024
File No. 333-280922
Dear John Sperzel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Evan G. Smith